Last updated on August 2019

Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis


Find a site near you

Start Over

GSK Investigational Site

Phoenix, AZ United States
  Connect »

GSK Investigational Site

Sacramento, CA United States
  Connect »

GSK Investigational Site

Miami, FL United States
  Connect »

GSK Investigational Site

Tampa, FL United States
  Connect »

GSK Investigational Site

Manhasset, NY United States
  Connect »

GSK Investigational Site

New York, NY United States
  Connect »

GSK Investigational Site

Allentown, PA United States
  Connect »

GSK Investigational Site

Dallas, TX United States
  Connect »

GSK Investigational Site

Seattle, WA United States
  Connect »

GSK Investigational Site

Clermont-Ferrand, France
  Connect »

GSK Investigational Site

Grenoble Cedex 9, France
  Connect »

GSK Investigational Site

Basingstoke, United Kingdom
  Connect »

GSK Investigational Site

Edgbaston, United Kingdom
  Connect »

GSK Investigational Site

Glasgow, United Kingdom
  Connect »

GSK Investigational Site

Liverpool., United Kingdom
  Connect »

GSK Investigational Site

Manchester, United Kingdom
  Connect »

GSK Investigational Site

Middlesbrough, United Kingdom
  Connect »

GSK Investigational Site

Newcastle-upon-Tyne, United Kingdom
  Connect »

GSK Investigational Site

Nottingham, United Kingdom
  Connect »

GSK Investigational Site

Plymouth, United Kingdom
  Connect »

GSK Investigational Site

Sheffield, United Kingdom
  Connect »